Breaking News

Monrol to Establish a Legal Entity and Manufacturing Facility in Germany

The new facility will focus on the manufacture of SPECT products and radiopharmaceutical products for radioligand therapy.

Author Image

By: Charlie Sternberg

Associate Editor

Following an ongoing assessment of its entire operation, Eczacıbaşı-Monrol Nuclear Products Co. (Monrol) has decided to establish a legal entity and manufacturing facility in Germany.   The new facility will focus on the manufacture of SPECT products and radiopharmaceutical products for radioligand therapy such as Gallium-68 generator and n.c.a Lutetium-177. Developed by Monrol R&D teams, these products are widely used in the production of radiopharmaceuticals for cancer patients. The faci...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters